Clinical Trial Update: BALSTILIMAB on Viral Clearance in HPV+ Oropharyngeal Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for balstilimab evaluating viral clearance in HPV-positive oropharyngeal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection
• Oropharyngeal Cancer

Drugs mentioned

• Balstilimab (balstilimab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: HPV, Oropharyngeal Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING